<section class="trial-contact">
  <p>
    Review the trial details below and contact the OSF Clinical Trials team.
    If you are unsure which trial may be right for you, please contact us and a
    research coordinator will be in touch with you.
  </p>

  <h3>Study title</h3>
  <p>
    A Single-Arm, Phase 2 Study of Neoadjuvant Carboplatin and Mirvetuximab
    Soravtansine in Subjects With FRÎ±-Expressing Advanced-Stage Serous Epithelial
    Ovarian, Fallopian Tube or Primary Peritoneal Cancer
  </p>

  <h3>Contact</h3>
  <p>
    <strong>Phone:</strong>
    <a href="tel:18446734467">(844) 673-4467</a>
  </p>

  <p><strong>OR</strong></p>

  <p>
    <strong>Email:</strong>
    <a
      href="mailto:sfmc.clinicaltrials@osfhealthcare.org
        ?subject=Clinical%20Trial%20Inquiry
        &body=Hello%20OSF%20Clinical%20Trials%20Team%2C%0D%0A%0D%0A
        I%20am%20interested%20in%20learning%20more%20about%20the%20following%20clinical%20trial%3A%0D%0A%0D%0A
        Study%20Title%3A%20A%20Single-Arm%2C%20Phase%202%20Study%20of%20Neoadjuvant%20Carboplatin%20and%20Mirvetuximab%20Soravtansine%0D%0A
        NCT%20Number%3A%20NCT06890338%0D%0A
        OSF%20ID%3A%20ONC_PEO_101%0D%0A%0D%0A
        Thank%20you."
    >
      sfmc.clinicaltrials@osfhealthcare.org
    </a>
  </p>

  <p class="email-note">
    Clicking Email will open a pre-filled message with the NCT number, OSF ID, and
    study title when available.
  </p>
</section>
